Introduction
Methods
-
Written in a language other than English,
-
Not a published peer-reviewed original research article (e.g. review, commentary or conference abstracts),
-
It was not stated whether HIV + individuals had received cART or were conducted in the pre-cART era (prior to 1996),
-
A cognitive screening measure that assessed HIV-associated cognitive impairment was not included;
-
The mean age of participants was below 18 years.
Results
HAND Screening Measures
Neuropsychological Gold Standard
Study | Premorbid ability | Motor/ fine motor | Attention /working memory | Psychomotor speed/ reaction time | Learning and memory | Executive function | Language | Visuoconstruction |
---|---|---|---|---|---|---|---|---|
[38] Chalermchai | GP | TMTA | BVMT | CT2 | SemFl | SemFl block design | ||
FT | CT1 | AVLT | First names | |||||
Coding SS | fluency | |||||||
[20] Sakamoto | GP | LNS PASAT | TMTA | SMLT | WCST | SemFl | ||
Coding | FMLT | LetFl | ||||||
SS | TMTB | |||||||
[31] Moore | GP | PASAT | TMTA | HVLT | CWT | SemFl | ||
Digit Span | Coding | BVMT | WCST | |||||
SS | LetFl | |||||||
Stroop Colour | ActFl | |||||||
TMTB | ||||||||
[21] Becker | X |
aX | X | X | X | |||
[34] Joska | FT | Coding | BVMT | CT2 | ||||
GP | CT1 | HVLT | CWT | |||||
TMTA | MAT | |||||||
MCT | ||||||||
[24] Levine | GP | LNS | Coding | BVMT | CWT | |||
PASAT | SS | HVLT | TMTB | |||||
LetFl | ||||||||
WSCT | ||||||||
[33] Simioni | NART | Digit Span | RT | TMTB | ||||
SpWM | TMTA | |||||||
VIP | ||||||||
[22] Skinner | GP |
bCalCAP | TMTB | |||||
SDMT | ||||||||
TMTA | ||||||||
[40] Morgan | GP | LNS | Coding | BVMT | TMTB | |||
PASAT | SS | HVLT | LetFl | |||||
TMTA | WCST | |||||||
[35] Singh | Digit Span | TMTA | TMTB | |||||
[32] Bottiggi | NART | FO | Ruff 2 and 7 | SDMT | FMLT | CWT | RCFT copy | |
GP | Seq RT | TMTA | RAVLT | TMTB | ||||
TG | LetFl | |||||||
[37] Wonja | GP | SDMT TMTA | RAVLT | CWT | ||||
VCRT | TMTB | |||||||
[25] Cysique | GP | Digit Span | SDMT | CVLT | Similarities | BNT | RCFT copy | |
TMTA | RCFT 3 min | TMTB | SemFl | |||||
LetFl | ||||||||
[30] Ellis | Vocabulary | TG | PASAT | SS | HVLT | |||
GP | ||||||||
[45] Richardson | GP | Digit Span |
bCalCAP TMTA | RAVLT | CWT | RCFT copy | ||
TMTB | ||||||||
[29] Sacktor (American) | GP |
bCalCAP | RAVLT | Odd man | RCFT copy | |||
SDMT | Out | |||||||
LetFl | ||||||||
[29] Sacktor (Ugandan) | GP | Digit Span | CT1 | VLT | CT2 | |||
TG | SDMT | |||||||
[23] Carey | GP | LNS | Coding | BVMT | CWT | SemFl | ||
PASAT | SS | HVLT | HCT | |||||
TMTA | TMTB | |||||||
LetFl | ||||||||
WCST | ||||||||
[27] Gonzalez | GP | Digit span | CT1 | RAVLT | CT2 | Block design | ||
PASAT | SDMT | CWT | ||||||
VisSp | TMTA | HCT | ||||||
TMTB | ||||||||
LetFl | ||||||||
[39] Smith | GP | LNS |
bCalCAP | CVLT | CT2 | |||
CT1 | Faces | CWT |
Sample Characteristics
Impairment Classification Criteria and Rate
Study | Screen | NP IR | Screen IR | Cut-off | Sub-sample | Sensitivity | Specificity | Accuracy |
---|---|---|---|---|---|---|---|---|
[40] Morgan | HDS | 43a
| - |
T < 40 | HAD only | 93 | 73 | - |
[31] Moore | 4 NP tests | 19b
| - | 4 tests T < 40, or
| - | 87 | 87 | - |
2 tests T < 40 + 1 | ||||||||
test T < 35, or
| ||||||||
2 tests T < 35, | ||||||||
or 1 test T < 40 + | ||||||||
1 test T < 30, | ||||||||
or 1 test T < 25 | ||||||||
[31] Moore | 3 NP tests | 19b
| - | 3 tests T < 40 or
| - | 87 | 76 | - |
1 test T < 40 + 1 | ||||||||
test T < 35, or
| ||||||||
1 test T < 30 | ||||||||
[25] Cysique | CogState | 62c
| 62c
| - | - | 81 | 70 | - |
[23] Carey | NP tests (HVLT-R& ndGP) | 29c
| 34c
|
T < 40 on 1 test or
| - | 78 | 85 | 83 |
T < 35 on 2 tests | ||||||||
[40] Morgan | HDS | 43c
| - |
T < 40 | MND only | 77 | 73 | - |
[23] Carey | NP tests (HVLT-R& Cod) | 29c
| - |
T < 40 on 1 test or
| - | 75 | 92 | 87 |
T < 35 on 2 tests | ||||||||
[31] Moore | 2 NP tests | 19c
| - | 2 tests T < 40 or
| - | 73 | 83 | - |
1 test T ≤ 35 | ||||||||
[29] Sacktor | IHDS(American) | 38c
| - | ≤10.5 | - | 71 | 79 | - |
[21] Becker | CAMCI | 31c
| 30c
| - | -g
| 72 | 98 | - |
[35] Singh | IHDS | 80c,f
| - | ≤10.5 | - | 94 | 25 | - |
[32] Bottiggi | HDS | 52c
| - | ≤10 | - | 93 | 38 | - |
[33] Simioni | HDS | 74c
| - | ≤14 | No self reported | 88 | 67 | - |
cognitive complaints | ||||||||
[35] Singh | IHDS | 80c,f
| - | ≤10 | - | 88 | 50 | - |
[29] Sacktor | IHDS (Ugandan) | 31c
| - | ≤9.5 | - | 88 | 48 | - |
[37] Wonja | HDS | 68b
| 48b,e
| ≤13 | - | 87 | 46 | - |
[38] Chalermchai | IHDS | 51c
| - | ≤10 | - | 86 | - | - |
[33] Simioni | HDS | 74c
| - | ≤14 | Self reported cognitive complaints | 83 | 63 | - |
[34] Joska | IHDS | 81b
| - | ≤11 | - | 81 | 54 | - |
[29] Sacktor | IHDS (American) | 38b
| - | ≤10 | - | 80 | 57 | - |
[22] Skinner | IHDS | 40b
| - | ≤10 | - | 77 | 65 | 70 |
[20] Sakamoto | HDS | 51c
| 12b
| ≤10 | moderate-severe impairment | 77 | - | - |
[24] Levine | NP tests | 52b
| 71c
|
T score (varied) | - | 75 | 61 | |
[20] Sakamoto | HDS | 51c
| 56c
|
T < 40 | - | 69 | 56 | 63 |
[27] Gonzalez | CalCAP | 57c
| 49c
| Average deficit | - | 68 | 77 | 72 |
[24] Levine | HDS | 52b
| 62c
| ≤10 | - | 67 | 50 | - |
[20] Sakamoto | HDS | 51c
| - | ≤14 | - | 66 | 61 | - |
[20] Sakamoto | HDS | 51c
| - | ≤10 | virologically suppressed only | 66 | 55 | 61 |
[20] Sakamoto | HDS | 51c
| 19b
| ≤10 | mild-moderate impairment | 65 | - | - |
[37] Wonja | HDS | 68b
| 48b,e
| ≤12 | - | 63 | 84 | - |
[20] Sakamoto | HDS | 51c
| 20b
| ≤10 | mild impairment | 63 | - | - |
[22] Skinner | HDS | 40b
| - | ≤11 | - | 62 | 80 | - |
[30] Ellis | 3 NP tests | 56c,d
| - | Averaged z-scores ≤ 0.5 | - | 58 | 82 | 68 |
[32] Bottiggi | HDS | 52c
| - | ≤10 | Moderate & severe impairment | 57 | 84 | - |
[45] Richaradson | HDS | 50c
| 40c
| ≤10 | - | 55 | 75 | 63 |
[33] Simioni | HDS | 74c
| - | ≤10 | - | 54 | 96 | - |
[38] Chalermchai | IHDS | 51c
| - | ≤10 | - | 53 | 89 | - |
[40] Morgan | HDS | 43b
| - |
T < 40 | ANI only | 50 | 73 | - |
[22] Skinner | HDS | 40b
| - | ≤10 | - | 46 | 80 | 67 |
[22] Skinner | MMSE | 40b
| - | ≤27 | - | 46 | 55 | - |
[34] Joska | IHDS | 81b
| - | ≤10 | - | 45 | 80 | 56 |
[30] Ellis | 3 NP tests | 56c,d
| 32c
| ≤1 SD 1 test | - | 44 | 84 | - |
[39] Smith | HDS | 49b
| - | ≤10 | - | 39 | 85 | - |
[40] Morgan | HDS | 43b
| - | ≤10 | HAD only | 36 | 94 | - |
[32] Bottiggi | HDS | 52c
| - | ≤10 | Severe impairment only | 36 | 94 | - |
[38] Chalermchai | IHDS | 51c
| - | ≤10 | - | 34 | 87 | - |
[30] Ellis | 3 NP tests | 56c,d
| 15c
| ≤1 SD on 1 test / ≤ 2 SD on 2 tests | - | 24 | 98 | - |
[20] Sakamoto | HDS | 51c
| 17c
| ≤10 | - | 24 | 92 | 57 |
[40] Morgan | HDS | 43b
| - | ≤10 | MND only | 23 | 94 | - |
[40] Morgan | HDS | 43b
| - | ≤10 | - | 17 | 94 | - |
[23] Carey | HDS | 29b
| 4b
| ≤11 | - | 9 | 98 | - |
[24] Levine | MMSE | 52b
| 14c
| ≤25 | - | 8 | 88 | - |
[30] Ellis | 3 NP tests | 56c,d
| - | Clinical rating ≥5 | - | 2 | 100 | 42 |
[40] Morgan | HDS | 43b
| - | ≤10 | ANI only | 0 | 94 | - |
N = 55 | Median Range | 51 | 33 | 66 | 80 | 65 | ||
19-81 | 4-71 | 0-93 | 25-100 | 42-87 |
Criterion Validity
Study | Screen | NP IR | Screen IR | Cut-off | Sample | Sensitivity | Specificity | Accuracy |
---|---|---|---|---|---|---|---|---|
[40] Morgan | HDS | 43a
| - |
T < 40
|
HAD only
| 93 | 73 | - |
[31] Moore | 4 NP tests | 19b
| - | 4 tests T < 40, or
| Entire sample | 87 | 87 | - |
2 tests T < 40 + 1 test T < 35, or
| ||||||||
2 tests T < 35, | ||||||||
or 1 test T < 40 + 1 test T < 30, | ||||||||
or 1 test T < 25 | ||||||||
[31] Moore | 3 NP tests | 19b
| - | 3 tests T < 40 or
| Entire sample | 87 | 76 | - |
1 testT < 40 + 1 test T < 35, or
| ||||||||
1 test T < 30 | ||||||||
[25] Cysique | CogState | 62a
| 62a
| - | Entire sample | 81 | 70 | - |
[23] Carey | NP tests (HVLT-R & ndGP) | 29a
| 34a
|
T < 40 on 1 test or T < 35 on 2 tests | Entire sample | 78 | 85 | 83 |
[40] Morgan | HDS | 43a
| - |
T < 40
|
MND only
| 77 | 73 | - |
[23] Carey | NP tests (HVLT-R & Cod) | 29a
| - |
T < 40 on 1 test or T < 35 on 2 tests | Entire sample | 75 | 92 | 87 |
[31] Moore | 2 NP tests | 19b
| - | 2 tests T < 40 or
| Entire sample | 73 | 83 | - |
1 test T ≤ 35 | ||||||||
[29] Sacktor (American) | IHDS | 38a
| - | ≤10.5 | Entire sample | 71 | 79 | - |
[21] Becker | CAMCI | 31a
| 30b
| - | Entire samplec
| 72 | 98 | - |
Construct Validity
Highest | Lowest | |||
---|---|---|---|---|
Study (screening measure) | Domain (NP test) |
r
| Domain (NP test) |
r
|
[34] Joska (IHDS) | Information processing speed (CT1) / memory (BVMT recall) | .35a
| Executive function (CT2) | .21a
|
[25] Cysique (CogState) | Fine motor skill (GPd) | .62b
| Visuoconstruction (RCFT copy) | -.22c
|
[39] Smith (CalCAP mini) | Executive function | .43d
| Fine motor skill | .22e
|